PRLD NASDAQ
Prelude Therapeutics Incorporated
1W: -5.4%
1M: -32.4%
3M: -26.4%
YTD: +34.4%
1Y: +143.1%
3Y: +19.5%
5Y: -89.4%
$3.67
-0.12 (-3.17%)
Weekly Expected Move ±9.4%
$3
$3
$4
$4
$4
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$22M
Revenue
+220.3% YoY
$-60M
Net Income
+51.3% YoY
$-33M
Free Cash Flow
+69.4% YoY
100.0%
Gross Margin
-270.9%
Op. Margin
-244.1%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-57.7%
ROA-39.8%
ROIC14236.3%
Valuation
P/E-4.6
P/B2.7
EV/EBITDA-6.6
Leverage
Debt/Equity0.13
Current Ratio4.07
Interest Cov.0.0x
Quality Scores
Piotroski F5/9
Altman Z0.23
Beneish M0.00